Exact Mass: 288.99496519999997
Exact Mass Matches: 288.99496519999997
Found 9 metabolites which its exact mass value is equals to given mass value 288.99496519999997,
within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error
0.0002 dalton.
(-)-8S-3-bromo-5-hydroxy-4-methoxyphenylalanine|2-amino-3-(3-bromo-5-hydroxy-4-methoxyphenyl)propanoic acid
C10H12BrNO4 (288.99496519999997)
3-AMINO-3-(3-BROMO-4-HYDROXY-5-METHOXY-PHENYL)-PROPIONIC ACID
C10H12BrNO4 (288.99496519999997)
3-AMINO-3-(5-BROMO-3-METHOXY-2-HYDROXY-PHENYL)-PROPIONIC ACID
C10H12BrNO4 (288.99496519999997)
Tizanidine hydrochloride
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D002491 - Central Nervous System Agents > D000700 - Analgesics Tizanidine hydrochloride is an α2-adrenergic receptor agonist and inhibits neurotransmitter release from CNS noradrenergic neurons. Target: α2-adrenergic receptor Tizanidine is a drug that is used as a muscle relaxant. It is a centrally acting α2 adrenergic agonist. It is used to treat the spasms, cramping, and tightness of muscles caused by medical problems such as multiple sclerosis, ALS, spastic diplegia, back pain, or certain other injuries to the spine or central nervous system. It is also prescribed off-label for migraine headaches, as a sleep aid, and as an anticonvulsant. It is also prescribed for some symptoms of fibromyalgia. Tizanidine has been found to be as effective as other antispasmodic drugs and has superior tolerability to that of baclofen and diazepam. Tizanidine can be very strong even at the 2 mg dose and may cause hypotension, so caution is advised when it is used in patients who have a history of orthostatic hypotension, or when switching from gel cap to tablet form and vice versa. Tizanidine can occasionally cause liver damage, generally the hepatocellular type. Clinical trials show that up to 5\% of patients treated with tizanidine had elevated liver function test values, though symptoms disappeared upon withdrawal of the drug. Care should be used when first beginning treatment with tizanidine with regular liver tests for the first 6 months of treatment.
AMINO-(3-BROMO-4,5-DIMETHOXY-PHENYL)-ACETIC ACID
C10H12BrNO4 (288.99496519999997)
1-Bromo-4,5-diethoxy-2-nitrobenzene
C10H12BrNO4 (288.99496519999997)
5-Bromo-1,2-dicarboxylic acid-1H-Pyrrole 1-(1,1-dimethylethyl) ester
C10H12BrNO4 (288.99496519999997)
(2s)-2-amino-3-(3-bromo-5-hydroxy-4-methoxyphenyl)propanoic acid
C10H12BrNO4 (288.99496519999997)
2-amino-3-(3-bromo-5-hydroxy-4-methoxyphenyl)propanoic acid
C10H12BrNO4 (288.99496519999997)